Independent Journalist,Former NY1 Anchor/Reporter, TEDx Speaker, Top 50 Irish America Power Women, Women in Tech Global Conf. Spkr
New York, NY
- Tweets 29,048
- Following 2,176
- Followers 36,291
- Likes 195,952
Pinned Tweet
Long Thread ... Thank you to our former producers who spoke up. Thank you for telling the truth. Thank you to
@dianafalzone @maxwellstrachan and @vicenews
for being brave enough to ask about the retaliation we've experienced. vice.com/en_us/article/3az8p…
258
450
856
kristen shaughnessy retweeted
To better serve our Substack community, we would appreciate your feedback.
With that in mind, please take 2 minutes to respond to this survey. Respondents will be entered for a chance to win a complimentary annual confidential insights membership on Substack.
LINK TO SURVEY BELOW:
2
1
9
2,980
$FNGR
CEO @jolie_kahn is a securities attorney.
Look at NASDAQ’s @FingerMotionInc stock since she took over in August - why isn’t she publicly demanding trade settlement ?
1.2 BILLION “Shares” traded on 8/28/26 and the company stays silent.
Why would any company go public?
@FlyEaglesFly529 @TintedVeil
$FNGR a flush at end of month to new low on news yesterday 5days/15minute chart. Near 46 million traded.
finance.yahoo.com/energy/art…
9
37
76
2,113
kristen shaughnessy retweeted
$FNGR
Make sure to email everyone involved in this scam
joliekahnlaw@sbcglobal.net CEO
andrew@irthcommunications.com IR Firm
brendan@irthcommunications.com IR Firm
daltman@ayrtonllc.com Ayrton Capital
trao@ayrtonllc.com Ayrton Capital
and tag tradingandmarkets@sec.gov
$FNGR
@jolie_kahn @rogerhamilton
Is anyone going to address the obvious fraud in this Nasdaq stock?
32 Million “Shares” trade by 8:41am?
@SECPaulSAtkins - is this another MMTLP?
nitter.siddz.com/kshaughnessy2/status/2…
@FlyEaglesFly529
2
20
47
1,138
Private Equity Invents “Act of AI” to Pause Loan Defaults Indefinitely
Private equity firms are trying to sneak “AI disruption” into loan contracts as an “act of God” , like a hurricane or pandemic.
That would let their companies delay fixing missed payments or other defaults for as long as they claim AI is hurting the business.
Money managers who lent the money are now digging through their paperwork, worried they already signed up for this open-ended escape hatch
12
35
64
3,389
kristen shaughnessy retweeted
$NWBO
The FDA can stop searching for another treatment for brain tumors. It should already have the data showing that DCVax-L is the best option available. Approve it, so more lives can be saved. Just a reminder. The MHRA has already fallen behind, after monitoring DCVax-L through the UK Specials program for more than 14 years.
If the FDA had held its Public Meeting on the Rare Disease Drug Development Framework before the MOU, it would have looked proactive. Coming after, it looks reactive.
piped.video/6kFkeH6eW0c?t=8064
nitter.siddz.com/d_stock07734/status/19…
$NWBO #DCVax #DCVaxForBraelyn #RareDisease #RareCancer #Immunotherapy #PatientAdvocacy #CancerResearch
🧬 𝗧𝗵𝗶𝘀 𝗺𝗼𝗿𝗻𝗶𝗻𝗴 𝗜 𝘁𝗼𝗼𝗸 𝘁𝗵𝗲 𝗰𝗮𝘀𝗲 𝗳𝗼𝗿 𝗗𝗖𝗩𝗮𝘅 𝘁𝗼 𝘁𝗵𝗲 𝗙𝗗𝗔.
A 21-page proposal with 52 cited sources, filed to the public docket for FDA’s 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗙𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 and sent to the Rare Disease Innovation Hub with a one-page summary. Both are in the images.
My advocacy is specific: 𝗗𝗖𝗩𝗮𝘅-𝗟 𝗮𝗻𝗱 𝗗𝗖𝗩𝗮𝘅-𝗗𝗶𝗿𝗲𝗰𝘁, beginning with rare cancers. I submitted this in my personal capacity as a physician and patient advocate. I am not affiliated with Northwest Biotherapeutics and do not speak for the company.
The ask: one published development example connecting three plans, the evidence, the tissue and manufacturing, and the patient’s route to care, so that a patient can begin treatment 𝗮𝗻𝗱 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗶𝘁. I asked FDA to name a coordinating office, publish a workplan within 90 days of the comment period closing, and include patients before key decisions are fixed.
One distinction runs through the whole proposal: more analyses of the same patients are not independent evidence.
FDA is inviting patients and advocates to shape this framework now, while it is still being designed. Behind every question about evidence, tissue or access is a family trying to keep someone alive.
𝗥𝗮𝗿𝗲 𝘀𝗵𝗼𝘂𝗹𝗱 𝗱𝗲𝘀𝗰𝗿𝗶𝗯𝗲 𝘁𝗵𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. 𝗜𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝗻𝗲𝘃𝗲𝗿 𝗱𝗲𝘀𝗰𝗿𝗶𝗯𝗲 𝘁𝗵𝗲 𝗮𝘁𝘁𝗲𝗻𝘁𝗶𝗼𝗻 𝗶𝘁𝘀 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗿𝗲𝗰𝗲𝗶𝘃𝗲.
📄 Docket: FDA-2026-N-12214
✅ Comment tracking: mvt-lzyl-zjmn
🔗 drive.google.com/file/d/1qvB…
1
28
89
4,319
kristen shaughnessy retweeted
$NWBO
@peterjkostis
@greta
@andrewcaravello
@DrOzCMS
@realDonaldTrump
We have a platform that works on cancer
Do we have any doctors at FDA or MHRA?
The $NWBO platform checks all of them.
But we have 27,000 dying per day from solid cancer tumors… remarkable
The Main Principles of the Hippocratic Oath
Do No Harm – Avoid causing unnecessary injury or suffering to patients.
Put Patients First – Act in the best interests of the patient.
Respect Life – Treat human life with dignity and respect.
Maintain Confidentiality – Protect patients’ private medical information.
Practice with Integrity – Be honest, ethical, and responsible.
Respect Medical Knowledge – Continue learning and maintain professional competence.
Treat Patients Equally – Provide care without discrimination.
2
5
410
kristen shaughnessy retweeted
$NWBO
The FDA has several pathways it could use to approve DCVax-L right away. Hundreds, if not more than a thousand, GBM patients have received DCVax-L through the UK Specials Program over the past 14 years. The FDA can always afford to wait. GBM patients can't.
$NWBO #DCVax #DCVaxForBraelyn #GBM #RareCancer #RareDisease
📣 𝗛𝗲𝗹𝗽 𝘀𝗵𝗮𝗽𝗲 𝘁𝗵𝗲 @FDA 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗙𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸.
12
43
1,762
$FNGR
@jolie_kahn @rogerhamilton
Is anyone going to address the obvious fraud in this Nasdaq stock?
32 Million “Shares” trade by 8:41am?
@SECPaulSAtkins - is this another MMTLP?
nitter.siddz.com/kshaughnessy2/status/2…
@FlyEaglesFly529
@SECPaulSAtkins @SECGov @WHFraudTF @DOJFraudDiv @FBI @FingerMotionInc if you can’t see the fraud here then idk what to say. 43 million traded in pre market and stock drops almost $0.10 on a $0.20 cent stock. Everyone who bought yesterday sold at a loss? Let’s be real. 🤡$FNGR
11
41
99
3,414
$NWBO
Rooting for @mfhugo1!
And asking again why American patients have to go overseas to get the DCVax platform - which is a promising Phase III treatment for all solid treatments, including glioblastoma and IS DEVELOPED by an American company - @NorthwestBio.
Meanwhile 19 year old @HollensbeBrae is on her way back to London for her fifth dose of the non-toxic DCVax.
Her latest MRI shows “no evidence” of the very aggressive glioblastoma she has been battling since she was 16.
Please let her, Mike Hugo and all patients with solid tumors get treatment here in the U.S. close to home.
@FDA @MHRAgovuk @SpimacoAddwaeih @aljedai @DrOzCMS @NHSBT @KCHAbuDhabi @realDonaldTrump @HollensbeAmanda @ThomasOwenMcCa1 @LisainNJUSA @andrewcaravello
Yesterday, I had the privilege of attending the FDA’s Rare Disease Framework Initiative public meeting.
I had brain surgery for recurrent Glioblastoma (GBM) just a few weeks ago, but I flew to Maryland for this meeting because this new framework has the potential to change the future of GBM.
I’ve fought this disease for 4.5 years, using every tool available. But my best chance now, at recurrence, is a treatment that is currently only accessible in the UK, a personalized cancer vaccine called DCVaxL.
I made sure to freeze my tumor tissue specifically so I could have a chance at getting this vaccine. I should find out within the next week or two whether my tissue sample is adequate for vaccine manufacturing. More details to come.
@HollensbeAmanda @LoriMills4CA42 @andrewcaravello @intrstedobservr
2
28
106
2,702
You know we are almost there when the financial media reports what we’ve been cautioning for years
“Private credit markets are deteriorating rapidly, with default rates hitting record highs and refinancing conditions worsening amid rising interest rates…”
4
31
108
2,915
$NWBO
“ 𝗧𝗵𝗶𝘀 𝗺𝗼𝗿𝗻𝗶𝗻𝗴 𝗜 𝘁𝗼𝗼𝗸 𝘁𝗵𝗲 𝗰𝗮𝘀𝗲 𝗳𝗼𝗿 𝗗𝗖𝗩𝗮𝘅 𝘁𝗼 𝘁𝗵𝗲 𝗙𝗗𝗔.
A 21-page proposal with 52 cited sources, filed to the public docket for FDA’s 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗙𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 and sent to the Rare Disease Innovation Hub with a one-page summary. Both are in the images…”
- @andrewcaravello
Details in post below
👇👇👇
@SpimacoAddwaeih @aljedai @MHRAgovuk @NHS @NHSEngland @NHSBT @FDA @DrOzCMS @realDonaldTrump
$NWBO #DCVax #DCVaxForBraelyn #RareDisease #RareCancer #Immunotherapy #PatientAdvocacy #CancerResearch
🧬 𝗧𝗵𝗶𝘀 𝗺𝗼𝗿𝗻𝗶𝗻𝗴 𝗜 𝘁𝗼𝗼𝗸 𝘁𝗵𝗲 𝗰𝗮𝘀𝗲 𝗳𝗼𝗿 𝗗𝗖𝗩𝗮𝘅 𝘁𝗼 𝘁𝗵𝗲 𝗙𝗗𝗔.
A 21-page proposal with 52 cited sources, filed to the public docket for FDA’s 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗙𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 and sent to the Rare Disease Innovation Hub with a one-page summary. Both are in the images.
My advocacy is specific: 𝗗𝗖𝗩𝗮𝘅-𝗟 𝗮𝗻𝗱 𝗗𝗖𝗩𝗮𝘅-𝗗𝗶𝗿𝗲𝗰𝘁, beginning with rare cancers. I submitted this in my personal capacity as a physician and patient advocate. I am not affiliated with Northwest Biotherapeutics and do not speak for the company.
The ask: one published development example connecting three plans, the evidence, the tissue and manufacturing, and the patient’s route to care, so that a patient can begin treatment 𝗮𝗻𝗱 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗶𝘁. I asked FDA to name a coordinating office, publish a workplan within 90 days of the comment period closing, and include patients before key decisions are fixed.
One distinction runs through the whole proposal: more analyses of the same patients are not independent evidence.
FDA is inviting patients and advocates to shape this framework now, while it is still being designed. Behind every question about evidence, tissue or access is a family trying to keep someone alive.
𝗥𝗮𝗿𝗲 𝘀𝗵𝗼𝘂𝗹𝗱 𝗱𝗲𝘀𝗰𝗿𝗶𝗯𝗲 𝘁𝗵𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. 𝗜𝘁 𝘀𝗵𝗼𝘂𝗹𝗱 𝗻𝗲𝘃𝗲𝗿 𝗱𝗲𝘀𝗰𝗿𝗶𝗯𝗲 𝘁𝗵𝗲 𝗮𝘁𝘁𝗲𝗻𝘁𝗶𝗼𝗻 𝗶𝘁𝘀 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗿𝗲𝗰𝗲𝗶𝘃𝗲.
📄 Docket: FDA-2026-N-12214
✅ Comment tracking: mvt-lzyl-zjmn
🔗 drive.google.com/file/d/1qvB…
4
45
160
3,271
Crime in Real Time
$INLF ( Cayman-incorporated Chinese Nasdaq company with multiple reverse splits- follow the money)
-Float is 1.4 Million Shares
-96 Million “Shares” traded by 8:05am on 10/29/26
-“traded” its float 68X by 8:05am
$NCPL
-Float is 2 Million Shares
-10 Million “Shares” traded by 8:10am on 10/29/26
- 5x its float by 8:10am
@FlyEaglesFly529
1
12
35
2,245
$CRWV
“At the center of CoreWeave’s story is a growing debt burden, both on its balance sheet and in the form of special purpose vehicles, which fund specific projects.
Morningstar analysts Luke Yang and Javier Correonero expect CoreWeave’s total debt load to surpass $100 billion by 2030.
They say its aggressive financing makes it one of the most leveraged companies under Morningstar’s technology coverage..”
$CRWV
Nothing says “AI revolution” like three co-founders sprinting for the exits.
“CoreWeave's three co-founders have sold a combined $3.3 billion of company stock since the AI data center operator's March 2025 IPO, with $2.4 billion of that coming in 2026 alone.
CEO Michael Intrator has offloaded more than $907 million this year,
Brannin McBee has reduced his stake by 40.4% of his IPO holdings,
and Brian Venturo has sold over $1.2 billion cumulatively…”
3
16
53
3,219
$NWBO
19-year-old @HollensbeBrae and her mom, @HollensbeAmanda, spent about six weeks in London this summer so Braelyn could receive DCVax, a promising nontoxic glioblastoma treatment from @NorthwestBio, a small American biotech.
They have a big thank you to all of you as they head overseas yet again for the next treatment.
When Braelyn was diagnosed at 16, she was given one to three months to live.
After her latest surgery, proton radiation, and three doses of DCVax, her latest MRI shows “No Evidence of Disease.”
Despite decades of promising results and long-term survivors, Braelyn still can’t get this treatment in the U.S.
When will the FDA and politicians let an American patient receive this American-developed treatment at home?
@SpimacoAddwaeih @aljedai
@MHRAgovuk @KCHLSAUDI @KCHAbuDhabi
$NWBO
It appears Braelyn’s story has made it to @POTUS
@HollensbeAmanda responds to @DrOz’s report this morning.
Included in this video - Video #17 of Braelyn’s celebration and the Hollensbe’s “Thank You”
16 short video 🧵of Braelyn’s story below.
Thanks for the find @pammirama!
Maybe Braelyn can get her November treatment by @NorthwestBio, an American company, in the U.S.??
6
45
153
6,776